Company intelligence / Profile preview

Aixial Group

Paris, Ile de France, Franceaixialgroup.com ↗

Ownership: Private
Development stage: Other

Overview

Aixial Group specializes in the design and execution of clinical trials, with expertise in oncology, radiopharmaceuticals, cell & gene therapy, rare diseases, and real-world evidence. The company provides biostatistics, data management, medical writing, regulatory affairs consulting and has recently migrated part of its portfolio onto the Medidata Platform to streamline studies and accelerate database lock. As a CRO it does not report its own clinical results or pipeline.

Therapeutic areas: OtherOncologyRare Diseases
Modalities: Cell & gene therapyRadiopharmaceuticalsSmall MoleculesBiologics
Industry: Contract Research Organization

Partnerships

Medidata/Dassault Systèmes

Beyond the preview

Go deeper on Aixial Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aixial Group.

Explore the full profile